[Antibiotic sensitivity and treatment recommendations for Streptococcus pneumoniae]

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Streptococcus pneumoniae is a leading cause of bacterial infections worldwide.
• Antibiotic resistance in S. pneumoniae poses a significant public health challenge.
• Understanding regional resistance patterns is crucial for effective treatment strategies.

Purpose of the Study:

• To assess the antibiotic susceptibility of Streptococcus pneumoniae isolates in the Navarra region.
• To review current treatment recommendations for S. pneumoniae infections.
• To guide appropriate clinical management based on local resistance data.

Main Methods:

• Collected data on patient demographics, sample source, diagnosis, and antibiotic susceptibility for S. pneumoniae isolates from October 2000 to September 2002.
• Analyzed 465 S. pneumoniae isolates, including 166 from invasive infections.
• Determined resistance rates to common antibiotics like penicillin, amoxicillin, cefotaxime, and erythromycin.

Main Results:

• Isolates from ear swabs showed higher resistance compared to blood culture isolates.
• 43% of S. pneumoniae isolates were resistant to penicillin, 6.1% to amoxicillin, and 6.6% to cefotaxime.
• 32.3% of strains exhibited multidrug resistance, with erythromycin resistance linked to MLSB and M phenotypes.

Conclusions:

• While resistance to beta-lactams like penicillin and amoxicillin is notable, it does not preclude their clinical use for most S. pneumoniae infections in the region.
• Treatment of pneumococcal meningitis may require alternative antibiotic strategies due to resistance patterns.
• Continued surveillance of S. pneumoniae antibiotic susceptibility is essential for public health.